Healthcare products developed by women, for women.
Healthcare products developed by women, for women.
![](https://fpghc.com/wp-content/uploads/2018/05/we-are-here-for-women.png)
We are here for women.
Our products, developed by women scientists, address the medical needs of nearly 100 million women in the U.S.
![](https://fpghc.com/wp-content/uploads/2018/05/icon-1-in-4.png)
1 in 4 women suffer from Vaginal Atrophy
![](https://fpghc.com/wp-content/uploads/2018/05/icon-1-in-5.png)
1 in 5 women suffer from Fribocystic Breast Disease
![](https://fpghc.com/wp-content/uploads/2018/05/icon-1-in-6.png)
1 in 6 women suffer from Overactive Bladder
![](https://fpghc.com/wp-content/uploads/2018/05/icon-1-in-20.png)
![](https://fpghc.com/wp-content/uploads/2018/05/icon-1-in-20-tablet.png)
![](https://fpghc.com/wp-content/uploads/2018/05/icon-1-in-20-phone.png)
1 in 20 women suffer from
Endometriosis
![](https://fpghc.com/wp-content/uploads/2018/05/help-women.png)
How we help women.
FemmePharma’s patented and highly targeted drug delivery technology is currently being used in a number of prescription and OTC products.
![](https://fpghc.com/wp-content/uploads/2018/06/prescription-products.jpg)
Prescription Products
FemmePharma’s clinical stage prescription products are highly targeted to address the condition or disease, while eliminating side effects.
![](https://fpghc.com/wp-content/uploads/2018/06/OTC-products.jpg)
OTC Products
FemmePharma’s Over the Counter products are designed to provide symptomatic relief with attention to convenience, ease, and elegance.
![](https://fpghc.com/wp-content/uploads/2018/05/icon-involvement.png)
Our involvement in the community.
Our mission goes beyond product development. We are committed to supporting and educating people on the conditions and issues that disproportionately affect women.
![FemmePharma President and CEO to Participate in Panel Discussion on the Opioid Addiction Crisis](https://fpghc.com/wp-content/uploads/2018/07/president-ceo-meeting.jpg)
FemmePharma President and CEO to Participate in Panel Discussion on the Opioid Addiction Crisis
Wayne, PA, March 1, 2018 Share this article: FemmePharma Global Healthcare, Inc. announced today that Gerianne Tringali DiPiano, President and Chief Executive Officer, has been asked to participate in a panel discussion on Legal Responses to the Opioid...
read more![FemmePharma President and CEO to Join Conversation on Business Exit Strategies](https://fpghc.com/wp-content/uploads/2018/07/exittrapsandtriumphs.png)
FemmePharma President and CEO to Join Conversation on Business Exit Strategies
Wayne, PA, April 2, 2018 Share this article: FemmePharma Global Healthcare, Inc. announced today that Gerianne Tringali DiPiano, President and Chief Executive Officer, has been asked to participate in an interactive panel discussion on Exits—Traps and...
read more![](https://fpghc.com/wp-content/uploads/2018/05/icon-gmp.png)